(2S,4R)-4-hydroxy-1-[(2S)-2-[[2-[4-[4-[6-(2-hydroxyphenyl)-3-methoxypyridazin-4-yl]phenyl]piperazin-1-yl]acetyl]amino]-3,3-dimethylbutanoyl]-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide
C46H54N8O6S — CID 169132651
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S,4R)-4-hydroxy-1-[(2S)-2-[[2-[4-[4-[6-(2-hydroxyphenyl)-3-methoxypyridazin-4-yl]phenyl]piperazin-1-yl]acetyl]amino]-3,3-dimethylbutanoyl]-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide
(2S,4R)-4-hydroxy-1-[(2S)-2-[[2-[4-[4-[6-(2-hydroxyphenyl)-3-methoxypyridazin-4-yl]phenyl]piperazin-1-yl]acetyl]amino]-3,3-dimethylbutanoyl]-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide (PubChem CID 169132651) has the molecular formula C46H54N8O6S and a molecular weight of 847.06 g/mol. Its IUPAC name is (2S,4R)-4-hydroxy-1-[(2S)-2-[[2-[4-[4-[6-(2-hydroxyphenyl)-3-methoxypyridazin-4-yl]phenyl]piperazin-1-yl]acetyl]amino]-3,3-dimethylbutanoyl]-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide.
Molecular Properties
| Compound Name | (2S,4R)-4-hydroxy-1-[(2S)-2-[[2-[4-[4-[6-(2-hydroxyphenyl)-3-methoxypyridazin-4-yl]phenyl]piperazin-1-yl]acetyl]amino]-3,3-dimethylbutanoyl]-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide |
|---|---|
| PubChem CID | 169132651 |
| Molecular Formula | C46H54N8O6S |
| Molecular Weight | 847.06 g/mol |
| Exact Mass | 846.39 |
| IUPAC Name | (2S,4R)-4-hydroxy-1-[(2S)-2-[[2-[4-[4-[6-(2-hydroxyphenyl)-3-methoxypyridazin-4-yl]phenyl]piperazin-1-yl]acetyl]amino]-3,3-dimethylbutanoyl]-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide |
| SMILES | COc1nnc(-c2ccccc2O)cc1-c1ccc(N2CCN(CC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)c3ccc(-c4scnc4C)cc3)C(C)(C)C)CC2)cc1 |
| InChI | InChI=1S/C46H54N8O6S/c1-28(30-11-13-32(14-12-30)41-29(2)47-27-61-41)48-43(58)38-23-34(55)25-54(38)45(59)42(46(3,4)5)49-40(57)26-52-19-21-53(22-20-52)33-17-15-31(16-18-33)36-24-37(50-51-44(36)60-6)35-9-7-8-10-39(35)56/h7-18,24,27-28,34,38,42,55-56H,19-23,25-26H2,1-6H3,(H,48,58)(H,49,57)/t28-,34+,38-,42+/m0/s1 |
| InChIKey | BNCPODMRWWEFKE-INBBZAOVSA-N |
| XLogP | 5.45 |
| TPSA | 173.35 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 61 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 847.06 |
| LogP ≤ 5 | 5.45 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 12 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 169132651 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.